CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 48 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 4.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,493 | +12.7% | 2,549,134 | +7.9% | 0.00% | 0.0% |
| Q2 2023 | $14,629 | +64.2% | 2,363,211 | +2.2% | 0.00% | +100.0% |
| Q1 2023 | $8,907 | +20.4% | 2,313,433 | -3.1% | 0.00% | 0.0% |
| Q4 2022 | $7,400 | -99.9% | 2,387,167 | -2.4% | 0.00% | -50.0% |
| Q3 2022 | $9,833,000 | -18.0% | 2,445,983 | -0.6% | 0.00% | 0.0% |
| Q2 2022 | $11,986,000 | -47.2% | 2,461,130 | -2.7% | 0.00% | 0.0% |
| Q1 2022 | $22,681,000 | -3.0% | 2,528,583 | +21.8% | 0.00% | 0.0% |
| Q4 2021 | $23,384,000 | -29.3% | 2,076,770 | +2.9% | 0.00% | -33.3% |
| Q3 2021 | $33,091,000 | -24.5% | 2,017,873 | +0.3% | 0.00% | -25.0% |
| Q2 2021 | $43,858,000 | – | 2,011,073 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Index Venture Life Associates VI Ltd | 9,961,789 | $89,357,000 | 100.00% |
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $179,070,000 | 48.51% |
| Vida Ventures Advisors, LLC | 3,931,818 | $35,268,000 | 20.51% |
| OUP Management Co., LLC | 2,937,615 | $26,350,000 | 20.06% |
| Samsara BioCapital, LLC | 1,884,096 | $16,900,000 | 4.26% |
| Kynam Capital Management, LP | 669,100 | $6,002,000 | 1.95% |
| Cormorant Asset Management, LP | 2,489,894 | $22,334,000 | 1.72% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $86,846,000 | 0.79% |
| RA Capital Management | 3,577,094 | $32,087,000 | 0.70% |
| BVF INC/IL | 1,755,545 | $15,747,000 | 0.63% |